Literature DB >> 23114901

Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities.

François Jouret1, Renaud Lhommel, Olivier Devuyst, Laurence Annet, Yves Pirson, Ziad Hassoun, Nada Kanaan.   

Abstract

Cyst infection is a diagnostic challenge in patients with autosomal dominant polycystic kidney disease (ADPKD) because of the lack of specific manifestations and limitations of conventional imaging procedures. Still, recent clinical observations and series have highlighted common criteria for this condition. Cyst infection is diagnosed if confirmed by cyst fluid analysis showing bacteria and neutrophils, and as a probable diagnosis if all four of the following criteria are concomitantly met: temperature of >38°C for >3 days, loin or liver tenderness, C-reactive protein plasma level of >5 mg/dL and no evidence for intracystic bleeding on computed tomography (CT). In addition, the elevation of serum carbohydrate antigen 19-9 (CA19-9) has been proposed as a biomarker for hepatic cyst infection. Positron-emission tomography after intravenous injection of 18-fluorodeoxyglucose, combined with CT, proved superior to radiological imaging techniques for the identification and localization of kidney and liver pyocyst. This review summarizes the attributes and limitations of these recent clinical, biological and imaging advances in the diagnosis of cyst infection in patients with ADPKD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23114901     DOI: 10.1093/ndt/gfs352

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  27 in total

1.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

2.  Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics.

Authors:  T Suwabe; H Araoka; Y Ubara; K Kikuchi; R Hazue; K Mise; S Hamanoue; T Ueno; K Sumida; N Hayami; J Hoshino; A Imafuku; M Kawada; R Hiramatsu; E Hasegawa; N Sawa; K Takaichi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-08       Impact factor: 3.267

3.  Diagnostic utility of 18FDG-PET/CT for ADPKD cyst infection.

Authors:  Yoshinosuke Shimamura; Hideki Takizawa
Journal:  Clin Exp Nephrol       Date:  2017-09-14       Impact factor: 2.801

Review 4.  Polycystic kidney disease.

Authors:  Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres
Journal:  Nat Rev Dis Primers       Date:  2018-12-06       Impact factor: 52.329

5.  Efficacy of 4 Years of Octreotide Long-Acting Release Therapy in Patients With Severe Polycystic Liver Disease.

Authors:  Marie C Hogan; Tetyana Masyuk; Eric Bergstralh; Bill Li; Walter K Kremers; Lisa E Vaughan; Angela Ihrke; Amanda L Severson; Maria V Irazabal; James Glockner; Nicholas F LaRusso; Vicente E Torres
Journal:  Mayo Clin Proc       Date:  2015-07-09       Impact factor: 7.616

Review 6.  [What is evidence-based in the treatment of autosomal dominant polycystic kidney disease?]

Authors:  Vera Christine Wulfmeyer; Roland Schmitt
Journal:  Internist (Berl)       Date:  2021-10-28       Impact factor: 0.743

Review 7.  Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.

Authors:  Luiz Fernando Norcia; Erika Mayumi Watanabe; Pedro Tadao Hamamoto Filho; Claudia Nishida Hasimoto; Leonardo Pelafsky; Walmar Kerche de Oliveira; Ligia Yukie Sassaki
Journal:  Hepat Med       Date:  2022-09-29

Review 8.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

Review 9.  Symptomatic and complicated nonhereditary developmental liver cysts: cross-sectional imaging findings.

Authors:  Massimo Tonolini; Francesca Rigiroli; Roberto Bianco
Journal:  Emerg Radiol       Date:  2013-11-19

10.  (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in infected polycystic kidney disease.

Authors:  Anna N Paschali; Alexandros T Georgakopoulos; Nikoletta K Pianou; Constantinos D Anagnostopoulos
Journal:  World J Nucl Med       Date:  2015 Jan-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.